目次
1. 調査方法および範囲
1.1. 調査方法
1.2. 調査目的およびレポートの範囲
2. 定義および概要
3. エグゼクティブサマリー
3.1. 製品種類別抜粋
3.2. 用途別抜粋
3.3. エンドユーザー別抜粋
3.4. 地域別抜粋
4. ダイナミクス
4.1. 影響因子
4.1.1. 推進要因
4.1.1.1. ウェアラブルコンポーネントとの統合の拡大
4.1.1.2. XX
4.2. 抑制要因
4.2.1.1. 低額償還方針
4.3. 機会
4.3.1. 影響分析
5. 業界分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
6. 製品種類別
6.1. はじめに
6.1.1. 市場規模分析および前年比成長率（%） 製品種類別
6.1.2. 市場魅力度指数 製品種類別
6.2. ワイヤレスホルターモニター*
6.2.1. はじめに
6.2.2. 市場規模分析および前年比成長率分析（％）
6.3. 有線ホルターモニター
6.4. ポータブルホルターモニター
6.5. 携帯型心電図モニター
7. 用途別
7.1. はじめに
7.1.1. 用途別市場規模分析および前年比成長率（％）
7.1.2. 用途別市場魅力度指数
7.2. 不整脈*
7.2.1. はじめに
7.2.2. 市場規模分析および前年比成長率（％）
7.3. 心房細動
7.4. 徐脈および頻脈
7.5. 虚血性心疾患
7.6. その他
8. エンドユーザー別
8.1. はじめに
8.1.1. エンドユーザー別市場規模分析および前年比成長率（％）
8.1.2. エンドユーザー別市場魅力度指数
8.2. 病院*
8.2.1. はじめに
8.2.2. 市場規模分析および前年比成長率分析（％）
8.3. 外来外科センター（ASC）
8.4. 循環器センター
8.5. クリニック
8.6. 在宅医療施設
9. 地域別
9.1. はじめに
9.1.1. 市場規模分析および前年比成長率分析（％）、地域別
9.1.2. 市場魅力度指数、地域別
9.2. 北米
9.2.1. はじめに
9.2.2. 主要地域特有のダイナミクス
9.2.3. 市場規模分析および前年比成長率分析（％）、製品種類別
9.2.4. 用途別市場規模分析および前年比成長率（％）
9.2.5. エンドユーザー別市場規模分析および前年比成長率（％）
9.2.6. 国別市場規模分析および前年比成長率（％）
9.2.6.1. 米国
9.2.6.2. カナダ
9.2.6.3. メキシコ
9.3. ヨーロッパ
9.3.1. はじめに
9.3.2. 主要地域別の動向
9.3.3. 市場規模分析および前年比成長率分析（％）、製品種類別
9.3.4. 市場規模分析および前年比成長率分析（％）、用途別
9.3.5. エンドユーザー別市場規模分析および前年比成長率（％）
9.3.6. 国別市場規模分析および前年比成長率（％）
9.3.6.1. ドイツ
9.3.6.2. 英国
9.3.6.3. フランス
9.3.6.4. スペイン
9.3.6.5. イタリア
9.3.6.6. ヨーロッパのその他地域
9.4. 南アメリカ
9.4.1. はじめに
9.4.2. 主要地域特有の動向
9.4.3. 市場規模分析および前年比成長率分析（％）、製品種類別
9.4.4. 用途別市場規模分析および前年比成長率（％）
9.4.5. エンドユーザー別市場規模分析および前年比成長率（％）
9.4.6. 国別市場規模分析および前年比成長率（％）
9.4.6.1. ブラジル
9.4.6.2. アルゼンチン
9.4.6.3. 南米その他
9.5. アジア太平洋地域
9.5.1. はじめに
9.5.2. 主要地域特有の動向
9.5.3. 製品種類別市場規模分析および前年比成長率分析（％）
9.5.4. 用途別市場規模分析および前年比成長率分析（％）
9.5.5. エンドユーザー別市場規模分析および前年比成長率（％）
9.5.6. 国別市場規模分析および前年比成長率（％）
9.5.6.1. 中国
9.5.6.2. インド
9.5.6.3. 日本
9.5.6.4. 韓国
9.5.6.5. アジア太平洋地域その他
9.6. 中東およびアフリカ
9.6.1. はじめに
9.6.2. 主要地域特有の動向
9.6.3. 市場規模分析および前年比成長率分析（％）、製品種類別
9.6.4. 市場規模分析および前年比成長率分析（％）、用途別
9.6.5. 市場規模分析および前年比成長率分析（％）、エンドユーザー別
10. 競合状況
10.1. 競合シナリオ
10.2. 市場ポジショニング/シェア分析
10.3. 合併・買収分析
11. 企業プロフィール
GE Healthcare
Philips Healthcare
VitalConnect
Vivalink
Cardioline SpA
Schiller AG
Midmark Corporation
Nasiff Associates, Inc.
Biomedical Instruments Co., Ltd.
iRhythm Technologies, Inc.
(リストは網羅的なものではありません)
12. 付録
12.1 当社およびサービスについて
12.2 お問い合わせ
The global holter analysis system & software market reached US$ 1.24 billion in 2023 and is expected to reach US$ 2.84 billion by 2031, growing at a CAGR of 10.9% during the forecast period 2024-2031.
The Holter Analysis System is a medical tool that continuously monitors the heart's electrical activity over 24 to 48 hours. It captures real-time ECG data through electrodes on the patient's chest, identifying and analyzing cardiac irregularities that may not be detected during standard ECGs. Modern Holter systems, developed by Hillrom and Philips, use advanced software for data analysis and reporting, allowing healthcare providers to import recordings from remote sites and export electronic reports securely, ensuring compliance with HIPAA regulations. Notable features include scanning modes, bidirectional interfaces, and sophisticated signal processing algorithms for improved diagnostic accuracy.
Market Dynamics: Drivers & Restraints
Growing Integration with Wearable Component
The global holter analysis system and software market is driven by the increasing integration with wearable Component. Health-conscious consumers are increasingly using wearable devices for fitness and health monitoring, which enhances the user experience by allowing patients to monitor their heart health alongside other health metrics. This convergence not only increases the visibility of Holter monitoring systems in the digital health ecosystem but also promotes greater patient engagement and adherence to monitoring protocols. As patients become more proactive in managing their health, the demand for advanced Holter monitoring solutions is expected to rise, driving market growth.
For instance, in August 2024, iRhythm Technologies, a leading digital health care company, has launched its Zio monitor and long-term continuous (LTCM) ambulatory ECG monitoring service in Austria, the Netherlands, Spain, and Switzerland. The Zio monitor and ZEUS system received CE Marking Under Medical Device Regulation in December 2023. The LTCM service offers up to 14 days of continuous, uninterrupted ECG monitoring, a significant advancement in these countries compared to older Holter monitoring services.
Low Reimbursement Policies
The global Holter Analysis System and Software market faces a significant challenge due to low reimbursement policies for Holter monitoring procedures. In many regions, particularly in developing countries, insurance coverage for Holter monitoring is limited or non-existent, creating financial barriers for healthcare providers and patients. This discourages the adoption of Holter monitoring systems, leading many facilities to opt for less costly alternatives or traditional methods. The financial constraints necessitate a reevaluation of the Holter monitoring system's value proposition to ensure its recognition as essential for effective cardiac care and management.
For more details on this report – Request for Sample
Segment Analysis
The global holter analysis system & software market is segmented based on product type, component, application, end user and region.
Product type:
Wireless Holter Monitor segment is expected to dominate the holter analysis system & software market share
The wireless holter monitor segment holds a major portion of the holter analysis system & software market share and is expected to continue to hold a significant portion of the holter analysis system & software market share during the forecast period.
Surgical instruments are essential tools for various medical procedures, including routine surgeries and complex interventions. They ensure precision, efficiency, and safety. The increasing prevalence of chronic diseases and the number of surgical procedures worldwide have driven the demand for high-quality, specialized instruments. Technological advancements, such as titanium and stainless steel integration, have improved the durability, sterility, and ergonomics of these instruments. Disposable surgical instruments have also addressed concerns about cross-contamination and infection control. The focus on improving surgical outcomes and reducing patient recovery times has further highlighted the importance of surgical instruments in the Holter Analysis System & Software market.
For instance, in September 2022, Borsam Biomedical Instruments has introduced its wireless ECG monitors, the 'Wireless ECG Monitor Event Recorder' and 'ECG Holter Recorder', which allow individuals to monitor their heart health remotely from the hospital. The Event Recorder records ECG data while the Holter is designed for longer-term wear and attaches to the chest using stickers and three leads.
End User:
Hospitals segment is the fastest-growing segment in holter analysis system & software market share
The hospitals segment is the fastest-growing segment in the holter analysis system & software market share and is expected to hold the market share over the forecast period.
Hospitals are the primary users of holter analysis system and software. They are increasingly focusing on preventive cardiology initiatives to address the increasing prevalence of cardiovascular diseases. Holter monitoring systems are crucial for this, providing continuous data collection for early detection and management of cardiac abnormalities. This proactive approach enhances patient outcomes and optimizes treatment plans. Hospitals have advanced infrastructure and technology that facilitate the integration of Holter monitoring systems into clinical workflows, improving diagnostic accuracy and streamlining patient data management. This solidifies hospitals' central role in driving Holter monitoring solutions in the evolving healthcare landscape.
Geographical Analysis
North America is expected to hold a significant position in the holter analysis system & software market share
North America holds a substantial position in the holter analysis system & software market and is expected to hold most of the market share.
Among the factors propelling the holter analysis system and software market in North America is the increasing prevalence of cardiovascular diseases (CVDs) among their aging populations. Indeed, North America records one of the highest incidences of heart conditions and thus the necessity for improved monitoring for early detection and management. Additionally, Increased acceptance of remote monitoring technologies has emerged, as both patients and healthcare professionals seek more convenient ways to take care of and manage health problems instead of confined hospital settings. Modernization and sophistication have characterized the advancements with Holter monitoring devices in technical terms. Consequently, North America is set to maintain a stronghold in the market due to continued investment in healthcare infrastructure and innovation.
For instance, in May 2024, Vivalink, a leading provider of digital healthcare solutions, has launched a technology solution for Mobile Cardiac Telemetry (MCT) and Holter monitoring. The solution integrates remote patient monitoring technologies and advanced arrhythmia detection algorithms, streamlining deployment and enhancing patient care. This integration aims to reduce the cost of ambulatory cardiac monitoring services by streamlining delivery and enhancing patient care.
Europe is growing at the fastest pace in the holter analysis system & software market
Europe holds the fastest pace in the holter analysis system & software market and is expected to hold most of the market share.
As life expectancy in various European countries increases, so does the number of health issues, especially those related to the heart, which require regular monitoring because of their age. According to the statistics presented by the European Union, the older population of 65 years and above comprises a significant share of its population. This translates into a growing demand for improved cardiac monitoring solutions like Holter systems. The modernization of healthcare facilities and improved service delivery in several European countries further enhance the availability and effectiveness of Holter monitoring technologies. The above considers changes in the demographical domain, however, growth in the market is witnessed by several challenges-for example, a shortage of skilled human resources to conduct accurate ECG analysis.
For instance, in November 2024, the medilogFD is a new SCHILLER 12-lead Holter ECG for spatial heart health analysis, offering a comprehensive assessment of cardiac ECG conditions. It detects atrial fibrillation/atrial flutter based on true P-wave analysis and can also provide additional respiratory information through the optional SpO2 sensor.
Competitive Landscape
The major global players in the holter analysis system & software market include GE Healthcare, Philips Healthcare, VitalConnect, Vivalink, Cardioline SpA, Schiller AG, Midmark Corporation, Nasiff Associates, Inc., Biomedical Instruments Co., Ltd., iRhythm Technologies, Inc. among others.
Emerging Players
The emerging players in the holter analysis system & software market include LifeSignals, Inc, Bardy Diagnostics, Inc and among others.
Key Developments
• In February 2024, UltraLinQ has launched its Holter Program during American Heart Month, featuring the UbiqVue Holter and ECG Interpretation Software. This innovative biosensor is designed to meet the needs of modern cardiology practices, making cardiac care seamless, accessible, and scalable. The Holter device and software are designed to manage ECG data and final reports.
Why Purchase the Report?
• Pipeline & Innovations: Insights into clinical trials, product pipelines, and upcoming advancements.
• Market Positioning: Analysis of product performance and growth potential for optimized strategies.
• Real-World Evidence: Integration of patient feedback for enhanced product outcomes.
• Physician Preferences: Insights into healthcare provider behaviors and adoption strategies.
• Regulatory & Market Updates: Coverage of recent regulations, policies, and emerging technologies.
• Competitive Insights: Analysis of market share, competitor strategies, and new entrants.
• Pricing & Market Access: Review of pricing models, reimbursement trends, and access strategies.
• Market Expansion: Strategies for entering new markets and forming partnerships.
• Regional Opportunities: Identification of high-growth regions and investment prospects.
• Supply Chain Optimization: Assessment of risks and distribution strategies.
• Sustainability & Regulation: Focus on eco-friendly practices and regulatory changes.
• Post-Market Surveillance: Enhanced safety and access through post-market data.
• Value-Based Pricing: Insights into pharmacoeconomics and data-driven R&D decisions.
The global holter analysis system & software market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2023
• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.
Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing Integration with Wearable Component
4.1.1.2. XX
4.2. Restraints
4.2.1.1. Low Reimbursement Policies
4.3. Opportunity
4.3.1. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Product type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
6.1.2. Market Attractiveness Index, By Product type
6.2. Wireless Holter Monitors*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Wired Holter Monitors
6.4. Portable Holter Monitors
6.5. Ambulatory ECG Monitors
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Arrhythmia*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Atrial Fibrillation
7.4. Bradycardia and Tachycardia
7.5. Ischemic Heart Disease
7.6. Others
8. By End User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers (ASCs)
8.4. Cardiac Centers
8.5. Clinics
8.6. Home Care Settings
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Spain
9.3.6.5. Italy
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. GE Healthcare*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Philips Healthcare
11.3. VitalConnect
11.4. Vivalink
11.5. Cardioline SpA
11.6. Schiller AG
11.7. Midmark Corporation
11.8. Nasiff Associates, Inc.
11.9. Biomedical Instruments Co., Ltd
11.10. iRhythm Technologies, Inc. (LIST NOT EXHAUSTIVE)
12. Appendix
12.1 About Us and Services
12.2 Contact Us
*** ホルター心電図解析装置＆ソフトウェアの世界市場に関するよくある質問(FAQ) ***
・ホルター心電図解析装置＆ソフトウェアの世界市場規模は？
→DataM Intelligence社は2023年のホルター心電図解析装置＆ソフトウェアの世界市場規模を12.4億米ドルと推定しています。
・ホルター心電図解析装置＆ソフトウェアの世界市場予測は？
→DataM Intelligence社は2031年のホルター心電図解析装置＆ソフトウェアの世界市場規模を28.4億米ドルと予測しています。
・ホルター心電図解析装置＆ソフトウェア市場の成長率は？
→DataM Intelligence社はホルター心電図解析装置＆ソフトウェアの世界市場が2024年～2031年に年平均10.9%成長すると展望しています。
・世界のホルター心電図解析装置＆ソフトウェア市場における主要プレイヤーは？
→「GE Healthcare、Philips Healthcare、VitalConnect、 Vivalink、Cardioline SpA、Schiller AG、Midmark Corporation、Nasiff Associates, Inc.、Biomedical Instruments Co., Ltd.、iRhythm Technologies, Inc.など ...」をホルター心電図解析装置＆ソフトウェア市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
